Connect with us

Business

Are CBD-Infused, Mood-Boosting Drinks the Hottest Trend in Cannabis for 2023? Consumers Are Paying Up!

Published

on

A CBD Monster Engery or perhaps a CBD Red Bull cocktail in 2023?

There is an ongoing trend of people turning away from alcoholic beverages, with several individuals seemingly making vows to stop alcoholic drinks consumption heading into the new year. Research on this trend has come up, showing that there is more substance to this sober curiosity than just a trendy dry January challenge.

Abstinence rituals like “Dry January” may be more than simply a social media trend, according to new data from consumer insights company Veylinx. More than 75% of Americans claim to have previously temporarily abstained from booze for at least one month. Half (46%) of drinkers are currently attempting to cut back on their alcohol intake, and 52% are doing so by switching to non-alcoholic beverages. The biggest motivations for cutting back on alcohol use, according to consumers, are to improve physical and mental health.

Non-alcoholic wine, liquor, and cocktails are becoming increasingly popular, driven by younger consumers. According to Veylinx CEO Anouar El Haji, people attempting to cut back on their drinking are discovering more and more substitutes on store shelves, in bars, and restaurants. According to the study, consumers are willing to pay higher prices for non-alcoholic variants of ready-to-drink cocktails. Brands have many chances for expansion in this market thanks to the emergence of the “sober inquisitive” movement.

The market for canned non-alcoholic cocktails is expanding quickly. Veylinx, a company that measures customer purchasing behaviors through behavioral research, analyzed the market to find out who exactly are the people buying these beverages and why. The study examined the demand for versions with functional advantages like mood enhancers, detoxifiers, and CBD.

In general, alcohol consumers are more willing to pay for canned drinks without alcohol than non-consumers. Additionally, those who claim to desire to cut back on their alcohol intake show a larger preference for non-alcoholic beverages.

For these customers, interest in non-alcoholic canned drinks is 13% higher than in alcoholic versions. The gap between consumers making attempts to drink less and the general public is even more obvious at high price points, where demand from these customers for non-alcoholic canned drinks is 71% greater at $20 for a four-pack.

CBD-INFUSED DRINKS/MOOD BOOSTERS

Drinks with CBD now exist in the US as part of a new wellness drink trend that promises consumers happier moods and calmer states of mind and provides minerals and vitamins.

The increased interest in these functional drinks coincides with wellness fads like healthy eating and sober curiosity. It is driven by an increase in the number of people who care about their health yet are also extremely stressed. According to a recent study, the market for functional beverages—which includes non-alcoholic drinks and those with additional vitamins, minerals, dietary fibers, Minerals, probiotics, and fruits—will grow to $156.43 billion by 2026. 

The CBD and mood-boosting versions of the canned non-alcoholic beverages tested work best, while the zero-calorie and natural detox versions fall short. Demand for a $12 four-pack of non-alcoholic canned cocktails jumps by 13% with the addition of CBD and by 9% with the addition of natural mood enhancers. The variant with added CBD is the most popular among men, driving 16% higher demand than a typical non-alcoholic drink. Women prefer the zero-calorie version the most, outpacing the standard version by 14%.

YOUNG CONSUMERS ARE LEADING THE TREND

Demographics and consumption patterns impact demand: The largest demand is seen among those aged 21 to 35, light drinkers, and those who have previously abstained from alcohol for about a month or more. All the non-alcoholic ideas have the greatest appeal to younger customers.

The demand for canned non-alcoholic beverages is 48% higher among people over 21 to 35 than among people over 35.

Adding CBD to drinks increases demand among consumers aged 21 to 35 by 18%.

The mood boost version, which contains natural adaptogens and nootropics, has the largest demand from people over 35 and generates 29% more demand than the regular non-alcoholic version.

Those who have previously participated in Dry January are more likely to make purchases—by 65%—than those who haven’t.

PRICE, TASTE, AND CHANCE ARE KEY TO GETTING MORE CUSTOMERS

The best ways to draw more customers into the category are through the chance to experience before you buy and superior flavor. The flavor, cost, and the fact that they have yet to try them before, according to consumers, are the top deterrents to buying non-alcoholic beverages. In line with this, more health advantages, the option to sample before purchasing, and better flavor were mentioned as reasons why individuals would choose to purchase these drinks in the future. One-fifth of shoppers prefer to give something a try first before making a buy.

CBD MOOD-BOOSTING DRINKS FOR YOU

These are two of the top CBD-infused drinks you could try.

Kaló Hemp Infused Seltzer-

You can choose from 8 various flavors of the Kaló Hemp Infused Seltzer, depending on your preferences. Raspberry Lime is a potent fusion of fresh citrus and sweet berries; Pomegranate Peach is a balanced blend of tart and sweet flavors; Lemon Lavender is full of citrus and has a calming taste; Strawberry Lemon is the ideal light summer beverage.

Kickback CBD Lemonade –

Kickback, a company that was established in 2016, was among the first to provide CBD-infused beverages, and they are now at the forefront of this quickly expanding sector. Their CBD beverages are produced with organic, premium ingredients and are intended to relieve tension and give you a functional chill.

ON THE RESEARCH

Veylinx employs behavioral research to determine how much consumers will pay for a product through a genuine bidding process, in contrast to traditional surveys where customers are only asked about their preferences. By putting sealed bids on things and then responding to questions about their justifications for buying or not buying, consumers can show their genuine willingness to pay. Consumers in the United States who were 21 years of age or older participated in the research in October 2022.

BOTTOM LINE

Following the desire to switch from(or stop drinking) alcoholic beverages, people are open to paying more for mood-boosting CBD-infused drinks as it is said to be in line with general wellness and eating healthy and not just as a means of jumping on the ‘dry January trend.’

Source: https://cannabis.net/blog/news/are-cbdinfused-moodboosting-drinks-the-hottest-trend-in-cannabis-for-2023-consumers-are-paying

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News